Ausgabe 2/2015
Inhalt (24 Artikel)
Chemotherapy-induced peripheral neuropathies in hematological malignancies
Joost Louis Marie Jongen, Annemiek Broijl, Pieter Sonneveld
Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells
Shingo Tanaka, Mitsutoshi Nakada, Daisuke Yamada, Ichiro Nakano, Tomoki Todo, Yasushi Ino, Takayuki Hoshii, Yuko Tadokoro, Kumiko Ohta, Mohamed A. E. Ali, Yutaka Hayashi, Jun-ichiro Hamada, Atsushi Hirao
PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Dimitrios Mathios, Jacob Ruzevick, Christopher M. Jackson, Haiying Xu, Sagar Shah, Janis M. Taube, Peter C. Burger, Edward F. McCarthy, Alfredo Quinones-Hinojosa, Drew M. Pardoll, Michael Lim
The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome
Lei Zhang, Yong Yan, Ying Jiang, Yong Cui, Yongxiang Zou, Jun Qian, Chun Luo, Yicheng Lu, Xiaojun Wu
Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas
Kristin Schneider, Astrid Weyerbrock, Soroush Doostkam, Karl Plate, Marcia Regina Machein
Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway
Yuewen Chao, Yan Wang, Xuejiao Liu, Peng Ma, Yi Shi, Jian Gao, Qiong Shi, Jinxia Hu, Rutong Yu, Xiuping Zhou
Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system
Ariz Akhter, Noraidah Masir, Ghaleb Elyamany, Kean-Chang Phang, Etienne Mahe, Ali Matar Al-Zahrani, Meer-Taher Shabani-Rad, Douglas Allan Stewart, Adnan Mansoor
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew D. Norden, David Schiff, Manmeet S. Ahluwalia, Glenn J. Lesser, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Alona Muzikansky, Jorg Dietrich, Benjamin Purow, Lisa M. Doherty, Debra C. LaFrankie, Julee R. Pulverenti, Jennifer A. Rifenburg, Sandra F. Ruland, Katrina H. Smith, Sarah C. Gaffey, Christine McCluskey, Keith L. Ligon, David A. Reardon, Patrick Y. Wen
Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
Amr Amin, M. Mustafa, E. Abd El-Hadi, A. Monier, A. Badwey, E. Saad
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume
Hong Rye Kim, Se-Hwan Kim, Jung-Il Lee, Ho Jun Seol, Do-Hyun Nam, Sung Tae Kim, Kwan Park, Jong Hyun Kim, Doo-Sik Kong
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
Martin K. Hunn, Evelyn Bauer, Catherine E. Wood, Olivier Gasser, Marina Dzhelali, Lindsay R. Ancelet, Brigitta Mester, Katrina J. Sharples, Michael P. Findlay, David A. Hamilton, Ian F. Hermans
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
Qiuting Wen, Laleh Jalilian, Janine M. Lupo, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael Prados, Sarah J. Nelson
Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2
Tobias Walbert, Tito R. Mendoza, Elizabeth Vera-Bolaños, Alvina Acquaye, Mark R. Gilbert, Terri S. Armstrong
Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma
Moran Artzi, Deborah T. Blumenthal, Felix Bokstein, Guy Nadav, Gilad Liberman, Orna Aizenstein, Dafna Ben Bashat
The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme
Lola B. Chambless, Heather M. Kistka, Scott L. Parker, Laila Hassam-Malani, Matthew J. McGirt, Reid C. Thompson
Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics
Walter Taal, Carin C. D. van der Rijt, Winand N. M. Dinjens, Peter A. E. Sillevis Smitt, Agnes A. A. C. M. Wertenbroek, Jacoline E. C. Bromberg, Irene van Heuvel, Johan M. Kros, Martin J. van den Bent
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab
Philipp Kickingereder, Benedikt Wiestler, Markus Graf, Sabine Heiland, Heinz Peter Schlemmer, Wolfgang Wick, Antje Wick, Martin Bendszus, Alexander Radbruch
Expert-validated CSF segmentation of MNI atlas enhances accuracy of virtual glioma growth patterns
A. Amelot, E. Stretton, H. Delingette, N. Ayache, S. Froelich, E. Mandonnet
Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy
Damien C. Weber, Carmen Ares, Robert Malyapa, Francesca Albertini, Gabriele Calaminus, Ulrike Kliebsch, Lorentzos Mikroutsikos, Petra Morach, Alessandra Bolsi, Tony Lomax, Ralf Schneider
Post progression survival in glioblastoma: where are we?
Enrico Franceschi, Mario Ermani, Stefania Bartolini, Marco Bartolotti, Rosalba Poggi, Giovanni Tallini, Gianluca Marucci, Antonio Fioravanti, Alicia Tosoni, Raffaele Agati, Antonella Bacci, Eugenio Pozzati, Luca Morandi, Damiano Balestrini, Claudio Ghimenton, Girolamo Crisi, Alba A. Brandes
Single agent vinorelbine in pediatric patients with progressive optic pathway glioma
Andrea Maria Cappellano, Antonio Sergio Petrilli, Nasjla Saba da Silva, Frederico Adolfo Silva, Priscila Mendes Paiva, Sergio Cavalheiro, Eric Bouffet
Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology
Tae-Young Jung, Ji Yeoun Lee, Dong-Seok Kim, Hyeon Jin Park, Chae-Yong Kim, Young-Shin Ra, Mee-Jeong Lee, Seong-Ho Kim, Hee-Jo Baek, Il Han Kim, Kyung Duk Park, Seung-Ki Kim
Diffusion weighted MRI is a promising imaging biomarker in brain metastases
R. Zakaria, M. D. Jenkinson
Comment on “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]
Thomas C. Booth, Adam D. Waldman, Sarah Jefferies, Rolf Jäger